BACKGROUND: Schizophrenia is a complex genetic disorder, with multiple putative risk genes and many reports of reduced cortical gray matter. Identifying the genetic loci contributing to these structural alterations in schizophrenia (and likely also to normal structural gray matter patterns) could aid understanding of schizophrenia's pathophysiology. We used structural parameters as potential intermediate illness markers to investigate genomic factors derived from single nucleotide polymorphism (SNP) arrays. METHOD: We used research quality structural magnetic resonance imaging (sMRI) scans from European American subjects including 33 healthy control subjects and 18 schizophrenia patients. All subjects were genotyped for 367 SNPs. Linked sMRI and genetic (SNP) components were extracted to reveal relationships between brain structure and SNPs, using parallel independent component analysis, a novel multivariate approach that operates effectively in small sample sizes. RESULTS: We identified an sMRI component that significantly correlated with a genetic component (r = -.536, p < .00005); components also distinguished groups. In the sMRI component, schizophrenia gray matter deficits were in brain regions consistently implicated in previous reports, including frontal and temporal lobes and thalamus (p < .01). These deficits were related to SNPs from 16 genes, several previously associated with schizophrenia risk and/or involved in normal central nervous system development, including AKT, PI3K, SLC6A4, DRD2, CHRM2, and ADORA2A. CONCLUSIONS: Despite the small sample size, this novel analysis method identified an sMRI component including brain areas previously reported to be abnormal in schizophrenia and an associated genetic component containing several putative schizophrenia risk genes. Thus, we identified multiple genes potentially underlying specific structural brain abnormalities in schizophrenia. Published by Elsevier Inc.
BACKGROUND: Schizophrenia is a complex genetic disorder, with multiple putative risk genes and many reports of reduced cortical gray matter. Identifying the genetic loci contributing to these structural alterations in schizophrenia (and likely also to normal structural gray matter patterns) could aid understanding of schizophrenia's pathophysiology. We used structural parameters as potential intermediate illness markers to investigate genomic factors derived from single nucleotide polymorphism (SNP) arrays. METHOD: We used research quality structural magnetic resonance imaging (sMRI) scans from European American subjects including 33 healthy control subjects and 18 schizophrenia patients. All subjects were genotyped for 367 SNPs. Linked sMRI and genetic (SNP) components were extracted to reveal relationships between brain structure and SNPs, using parallel independent component analysis, a novel multivariate approach that operates effectively in small sample sizes. RESULTS: We identified an sMRI component that significantly correlated with a genetic component (r = -.536, p < .00005); components also distinguished groups. In the sMRI component, schizophrenia gray matter deficits were in brain regions consistently implicated in previous reports, including frontal and temporal lobes and thalamus (p < .01). These deficits were related to SNPs from 16 genes, several previously associated with schizophrenia risk and/or involved in normal central nervous system development, including AKT, PI3K, SLC6A4, DRD2, CHRM2, and ADORA2A. CONCLUSIONS: Despite the small sample size, this novel analysis method identified an sMRI component including brain areas previously reported to be abnormal in schizophrenia and an associated genetic component containing several putative schizophrenia risk genes. Thus, we identified multiple genes potentially underlying specific structural brain abnormalities in schizophrenia. Published by Elsevier Inc.
Authors: Lukas Pezawas; Beth A Verchinski; Venkata S Mattay; Joseph H Callicott; Bhaskar S Kolachana; Richard E Straub; Michael F Egan; Andreas Meyer-Lindenberg; Daniel R Weinberger Journal: J Neurosci Date: 2004-11-10 Impact factor: 6.167
Authors: Michael L Mimmack; Margaret Ryan; Hajime Baba; Juani Navarro-Ruiz; Shuji Iritani; Richard L M Faull; Peter J McKenna; Peter B Jones; Heii Arai; Michael Starkey; Piers C Emson; Sabine Bahn Journal: Proc Natl Acad Sci U S A Date: 2002-04-02 Impact factor: 11.205
Authors: Derrek P Hibar; Jason L Stein; Omid Kohannim; Neda Jahanshad; Andrew J Saykin; Li Shen; Sungeun Kim; Nathan Pankratz; Tatiana Foroud; Matthew J Huentelman; Steven G Potkin; Clifford R Jack; Michael W Weiner; Arthur W Toga; Paul M Thompson Journal: Neuroimage Date: 2011-04-08 Impact factor: 6.556
Authors: Barnaly Rashid; Jiayu Chen; Ishtiaque Rashid; Eswar Damaraju; Jingyu Liu; Robyn Miller; Oktay Agcaoglu; Theo G M van Erp; Kelvin O Lim; Jessica A Turner; Daniel H Mathalon; Judith M Ford; James Voyvodic; Bryon A Mueller; Aysenil Belger; Sarah McEwen; Steven G Potkin; Adrian Preda; Juan R Bustillo; Godfrey D Pearlson; Vince D Calhoun Journal: Neuroimage Date: 2018-10-06 Impact factor: 6.556
Authors: Sharna Jamadar; Natalie R Powers; Shashwath A Meda; Vince D Calhoun; Joel Gelernter; Jeffrey R Gruen; Godfrey D Pearlson Journal: Brain Imaging Behav Date: 2013-03 Impact factor: 3.978
Authors: Jessica A Turner; Vince D Calhoun; Andrew Michael; Theo G M van Erp; Stefan Ehrlich; Judith M Segall; Randy L Gollub; John Csernansky; Steven G Potkin; Beng-Choon Ho; Juan Bustillo; S Charles Schulz; Lei Wang Journal: Twin Res Hum Genet Date: 2012-06 Impact factor: 1.587
Authors: Shashwath A Meda; Balaji Narayanan; Jingyu Liu; Nora I Perrone-Bizzozero; Michael C Stevens; Vince D Calhoun; David C Glahn; Li Shen; Shannon L Risacher; Andrew J Saykin; Godfrey D Pearlson Journal: Neuroimage Date: 2012-01-08 Impact factor: 6.556